| Trial ID: | L4438 |
| Source ID: | NCT05881213
|
| Associated Drug: |
Ckd-378 (Low-Dose)
|
| Title: |
Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy Adults
|
| Acronym: |
CKD-378
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type II Diabetes
|
| Interventions: |
DRUG: CKD-378 (low-dose)
|
| Outcome Measures: |
Primary: area under the curve (AUC)t of CKD-378, Area under the concentration-time curve time zero to time, Pre-dose(0 hour) to 48 hours|Cmax of CKD-378, Maximum plasma concentration of the drug, Pre-dose(0 hour) to 48 hours |
|
| Sponsor/Collaborators: |
Sponsor: Chong Kun Dang Pharmaceutical
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
23
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2023-06-01
|
| Completion Date: |
2023-07-10
|
| Results First Posted: |
|
| Last Update Posted: |
2023-12-19
|
| Locations: |
Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT05881213
|
